Patent Medical presents Symbionic Teeth in Vienna; no peri-implantitis in 12-year studies

Patent Medical presents Symbionic Teeth in Vienna

Vienna - At the 2026 International Osteology Symposium in Vienna, Patent Medical unveiled Symbionic Teeth, its advancement of current dental implants. According to the Swiss company, research at the University of Bern as well as long-term studies have found that its novel solution can completely prevent peri-implantitis.

(CONNECT)Patent Medicalfrom Altendorf in the Swiss canton of Schwyz hosted a corporate symposium on its next-generation dental implants,Symbionic Teeth, at this year’s Osteology Congress organized by theOsteology Foundation, which is based in Root in the canton of Lucerne. The conference took place in Vienna from 23 to 25 April. According to astatement, Patent Medical’s symposium, which was fully booked, was led by two Swiss experts: Prof. Dr. Dr. Anton Sculean, Director of theDepartment of Periodontologyat theUniversity of Bern, and Dr. Roland Glauser, a certified specialist in oral implantology and owner of thecosmodentdental clinic in Zurich.

Their presentation included robust evidence demonstrating why Symbionic Teeth can significantly reduce the biological complications that may arise following implantation, asserts the company in the statement. In two long-term studies conducted at universities in Germany and Austria, no peri-implantitis occurred in patients over observation periods of up to 12 years. Usually, this inflammatory disease of the bone and gum tissue surrounding a dental implant affects 22 per cent of implant patients.

In their research with histologists Dr. Peter Schüpbach and Prof. Dieter Bosshardt at the University of Bern, Sculean and Glauser concluded that epithelial cells begin to bond firmly to the transmucosal surface of Symbionic Teeth at a very early stage. As a result, unlike current dental implants, Symbionic Teeth integrate not only with bone but also with soft tissues. The resulting cellular bond, combined with the unique patented surface of Symbionic Teeth, acts as a mucosal defense barrier against plaque and bacteria, even in high-risk patients.

According to “MedTech Outlook”, Symbionic Teeth is the world’s first implant system to establish a bond between peri-implant soft tissues and the implant surface. For this “decisive breakthrough” in the prevention of peri-implantitis, the medical technology trade magazine named Patent Medical “Dental Implants Manufacturer of the Year in Europe 2025”. ce

Chipeno pairs truffles with chipotle chilies in new sauce

Mabylon secures Eurostars grant worth 1.46 million euros

SIG Group expands in Mexico

FREITAG launches multifunctional Easy Riders bags

BTRY wins Hermes Startup Award 2026

Transferring home ownership within the family remains popular, says Raiffeisen

Bug Bounty Switzerland secures 12 million Swiss francs

Sirin Orbital Systems to research with ESA and the University of Málaga

Wir sind auch auf folgenden Social Media-Plattformen präsent. Bitte folgen Sie uns auch dort.